Other conditions decisions — 2025

The Board remands the case to associate a copy of the July 2023 decision letter and request an updated notice of entitlement from DoD or a copy of the Appellant's high school diploma.

The Board dismissed the appeal due to the Veteran's death during the pendency of the appeal.

The Veteran is granted a total disability evaluation based on individual unemployability due to his service-connected disabilities, which meet the schedular requirements and render him unable to obtain or maintain substantially gainful employment.

The veteran withdrew the appeal for higher ratings of diabetic peripheral neuropathy in both lower extremities.

The Veteran withdrew his appeal for evaluations in excess of 20 percent for a back condition, left lower extremity radiculopathy, and right lower extremity radiculopathy.

The Board granted service connection for basal cell carcinoma of the left superior medial upper back, right ear, and right forearm based on in-service herbicide exposure.

The appeal concerning entitlement to payment of the cost of non-VA medical services provided on March 10, 2021, is denied.

The Board denied a compensable rating for the Veteran's right little finger disability, finding that it was manifested by arthritis with painful limitation of motion but did not more nearly approximate ankylosis or amputation.

The Veteran is granted a total disability rating based on individual unemployability and special monthly compensation at the housebound rate due to his service-connected psychiatric disability.

The veteran's appeal requests for both hypertension and hypothyroidism service connection were denied due to untimeliness, as the appeals were not filed within one year of the respective rating decisions.

The Board remands the claims for further development, including obtaining additional medical records and scheduling a VA examination.

The Board remands the issue of eligibility for benefits under the VA PCAFC to determine if it is in the best interest of the Veteran and other necessary criteria.

The Board denied the Veteran's claim for an initial compensable rating for essential thrombocytosis as there was no evidence of continuous or intermittent myelosuppressive therapy, chemotherapy, or interferon treatment.

The appeal for VR&E services was dismissed because the Veteran reapplied and received benefits while the current appeal was pending.

The Board is remanding the claim for further development and readjudication of entitlement to VR&E benefits under Chapter 31, Title 38, United States Code.

The Board dismissed the motion for revision based on clear and unmistakable error (CUE) in a July 15, 2019 rating decision.

The appellant's claim for VA home loan guaranty benefits was denied because she did not meet the minimum service duration requirements.

The appeal concerning entitlement to payment of the cost of non-emergency, non-VA medical services provided on February 10, 2021, is denied because such services were not authorized by VA.

The appeal concerning entitlement to payment of the cost of non-VA medical services provided on October 29, 2021, was denied due to lack of VA authorization.

The appeal of the July 2016 rating decision is dismissed as untimely.